Effectiveness of electroconvulsive therapy on treatment-resistant depressive disorder: A population-based mirror-image study

2020 ◽  
Vol 121 ◽  
pp. 101-107
Author(s):  
Chung-Yi Lin ◽  
I-Ming Chen ◽  
Hui-Ju Tsai ◽  
Chi-Shin Wu ◽  
Shih-Cheng Liao
2017 ◽  
Vol 44 (4) ◽  
pp. 798-806 ◽  
Author(s):  
Hai-Ti Lin ◽  
Shi-Kai Liu ◽  
Ming H Hsieh ◽  
Yi-Ling Chien ◽  
I-Ming Chen ◽  
...  

2016 ◽  
Vol 32 (2) ◽  
pp. 119-121 ◽  
Author(s):  
Jorge Mota ◽  
Nuno Rodrigues-Silva

2017 ◽  
Vol 33 (2) ◽  
pp. 104-110 ◽  
Author(s):  
Christoph Ziegelmayer ◽  
Göran Hajak ◽  
Anne Bauer ◽  
Marion Held ◽  
Rainer Rupprecht ◽  
...  

2016 ◽  
Vol 205 ◽  
pp. 130-137 ◽  
Author(s):  
Peter C.R. Mulders ◽  
Philip F.P. van Eijndhoven ◽  
Joris Pluijmen ◽  
Aart H. Schene ◽  
Indira Tendolkar ◽  
...  

2011 ◽  
Vol 2011 ◽  
pp. 1-7 ◽  
Author(s):  
Axel Nordenskjöld ◽  
Lars von Knorring ◽  
Ingemar Engström

Objective. The aim of the study is to define predictors of relapse/recurrence after electroconvulsive therapy, ECT, for patients with major depressive disorder.Methods. A study of all patients (n=486) treated by means of ECT for major depressive disorder was performed. The data were derived from a regional quality register in Sweden. Psychiatric hospitalisation or suicide was used as a marker for relapse/recurrence.Results. The relapse/recurrence rate within one year after ECT was 34%. Factors associated with increased risk of relapse/recurrence included comorbid substance dependence and treatment with benzodiazepines or antipsychotics during the follow-up period.Conclusions. Within the first years after ECT, relapses/recurrences leading to hospitalisation or suicide are common. Treatment with lithium might be beneficial, while benzodiazepines, antipsychotics, or continuation ECT does not seem to significantly reduce the risk of relapse/recurrence.


2020 ◽  
Vol 10 (1) ◽  
Author(s):  
Aron T. Hill ◽  
Itay Hadas ◽  
Reza Zomorrodi ◽  
Daphne Voineskos ◽  
Faranak Farzan ◽  
...  

Abstract Electroconvulsive therapy (ECT) is a highly effective neuromodulatory intervention for treatment-resistant major depressive disorder (MDD). Presently, however, understanding of its neurophysiological effects remains incomplete. In the present study, we utilised resting-state electroencephalography (RS-EEG) to explore changes in functional connectivity, network topology, and spectral power elicited by an acute open-label course of ECT in a cohort of 23 patients with treatment-resistant MDD. RS-EEG was recorded prior to commencement of ECT and again within 48 h following each patient’s final treatment session. Our results show that ECT was able to enhance connectivity within lower (delta and theta) frequency bands across subnetworks largely confined to fronto-central channels, while, conversely, more widespread subnetworks of reduced connectivity emerged within faster (alpha and beta) bands following treatment. Graph-based topological analyses revealed changes in measures of functional segregation (clustering coefficient), integration (characteristic path length), and small-world architecture following ECT. Finally, post-treatment enhancement of delta and theta spectral power was observed, which showed a positive association with the number of ECT sessions received. Overall, our findings indicate that RS-EEG can provide a sensitive measure of dynamic neural activity following ECT and highlight network-based analyses as a promising avenue for furthering mechanistic understanding of the effects of convulsive therapies.


Sign in / Sign up

Export Citation Format

Share Document